delta-9-tetrahydrocannabinol

GPTKB entity

Predicate	Object
gptkbp:instanceOf	gptkb:Cannabis gptkb:psychoactive_compound
gptkbp:abbreviation	gptkb:THC
gptkbp:aroma	distinctive
gptkbp:ATCCode	gptkb:N02BG10
gptkbp:boilingPoint	157°C
gptkbp:brand	gptkb:Marinol gptkb:Syndros
gptkbp:broadcastOn	gptkb:Schedule_I_(US_federal_law)
gptkbp:CASNumber	1972-08-3
gptkbp:chemicalFormula	C21H30O2
gptkbp:color	colorless oil
gptkbp:controlledSubstanceSchedule	yes
gptkbp:discoveredBy	gptkb:Raphael_Mechoulam
gptkbp:discoveredIn	1964
gptkbp:effect	euphoria altered perception analgesia increased appetite
gptkbp:eliminationHalfLife	1.6–59 hours
gptkbp:excretion	urine feces
gptkbp:flavor	gptkb:bitter
gptkbp:foundIn	cannabis
gptkbp:isomerOf	delta-8-tetrahydrocannabinol
gptkbp:IUPACName	gptkb:(−)-trans-Δ⁹-tetrahydrocannabinol
gptkbp:legalStatus	varies by country
gptkbp:meltingPoint	157°C
gptkbp:metabolism	liver
gptkbp:molecularWeight	314.464 g/mol
gptkbp:overdoseSymptoms	low
gptkbp:pregnancyCategory	not recommended
gptkbp:PubChem_CID	gptkb:ChEMBL651 16078
gptkbp:relatedTo	cannabidiol cannabinol
gptkbp:routeOfAdministration	oral inhalation sublingual
gptkbp:sideEffect	anxiety paranoia red eyes dry mouth impaired memory
gptkbp:solubility	lipid-soluble
gptkbp:target	gptkb:CB1_receptor gptkb:CB2_receptor
gptkbp:UNII	7J8887I17Q
gptkbp:usedFor	medical cannabis
gptkbp:bfsParent	gptkb:(−)-trans-Δ⁹-tetrahydrocannabinol gptkb:Sativex
gptkbp:bfsLayer	7
http://www.w3.org/2000/01/rdf-schema#label	delta-9-tetrahydrocannabinol